![](/img/cover-not-exists.png)
Routine use of granulocyte colony-stimulating factor is not cost-effective and does not increase patient comfort in the treatment of small-cell lung cancer: an analysis using a Markov model.
Chouaid, C, Bassinet, L, Fuhrman, C, Monnet, I, Housset, BVolume:
16
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.1998.16.8.2700
Date:
August, 1998
File:
PDF, 739 KB
1998